CHASITY HAMMOND: Open Payments
NPI 1902467178 · WINSTON SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,493 in 119 payments from 22 companies in 2025. Trend: 2023 $1,271 · 2024 $1,967 · 2025 $2,493
Food & beverage: $2,493
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 21 | $427 |
| ABBVIE INC. | 22 | $342 |
| Axsome Therapeutics, Inc. | 16 | $312 |
| AstraZeneca Pharmaceuticals LP | 8 | $282 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $273 |
| Getinge USA Sales, LLC | 1 | $117 |
| Vanda Pharmaceuticals Inc. | 4 | $95 |
| GlaxoSmithKline, LLC. | 5 | $84 |
| PFIZER INC. | 3 | $74 |
| Lilly USA, LLC | 4 | $71 |
Products named: Wegovy, Auvelity, CAPLYTA, VRAYLAR, AIRSUPRA, BREZTRI, VASOVIEW HEMOPRO 2, UBRELVY.
Industry payments across NC — which companies pay providers there.
